Protocols in Development
A Randomized Clinical Trial Evaluating Intravitreal Faricimab (6.0 mg) Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss due to Radiation Retinopathy – Protocol AL
A Phase 2 Study Evaluating Short-Term Efficacy of Tonabersat for Diabetic Macular Edema - Protocol AN
Home OCT-Guided Treatment versus Treat and Extend for the Management of Neovascular AMD - Protocol AO
Interested in participating on a Protocol Development Committee? Email Brittany Kelly (email@example.com) for details.